NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lockheed Martin Corporation ("Lockheed" or "the Company") (NYSE:LMT). Investors who purchased Lockheed securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/LMT. […]

NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Replimune Group, Inc. ("Replimune" or "the Company") (NASDAQ:REPL). Investors who purchased Replimune securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/REPL.

NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Geely Automobile Holdings Limited ("Geely" or "the Company") (OTCMKTS:GELYF)(OTCMKTS:GELYY). Investors who purchased Geely securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Geely Automobile Holdings Limited ("Geely" or "the Company") (OTCMKTS:GELYF; GELYY). Investors who purchased Geely securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

The hike in U.S. tariffs to 35% will harm small businesses on both sides of the border. Thefentanyl rationale is even more ridiculous than the decision itself. While it is good news that most Canadian exports will remain tariff free due to the CUSMA/USMCA exemption, the uncertainty alone will continue to take a toll on

NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ZEEKR Intelligent Technology Holding Limited ("Zeekr" or "the Company") (NASDAQ:ZK). Investors who purchased Zeekr securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GSK plc ("GSK" or "the Company") (NYSE:GSK). Investors who purchased GSK securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/GSK. Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Edgewise Therapeutics, Inc. ("Edgewise" or "the Company") (NASDAQ:EWTX). Investors who purchased Edgewise securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EWTX.

NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Unicycive Therapeutics, Inc. ("Unicycive" or "the Company") (NASDAQ:UNCY). Investors who purchased Unicycive securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/UNCY.

NEW YORK, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The J.M. Smucker Company ("Smucker" or "the Company") (NYSE:SJM). Investors who purchased Smucker securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SJM.